US FDA Warns Eli Lilly and Company, Sanofi-Aventis (France), Meda AB on Misleading Promotions

February 4, 2010 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

Reuters -- U.S. health officials have warned Sanofi Aventis SA, Eli Lilly & Co and Meda AB about misleading promotions for prescription drugs, letters released on Wednesday said.

Twitter
LinkedIn
Facebook
Email
Print

Legal Regulatory

Eli Lilly and Company Food and Drug Administration (FDA) Sanofi